Working Toward a Cure for Multiple Sclerosis
Run Time: 55:49
Hosted by Marc Pelletier, Futures in Biotech explores the latest trends and intriguing topics in biotechnology and related science disciplines. This episode focused on the incredible work being done by the Myelin Repair Foundation founded by Scott Johnson, a long-time sufferer of MS. The foundation is dedicated to finding a cure to multiple sclerosis, and has developed a bleeding edge research technique to accomplish this goal. The technique is called ARC (Accelerated Research Collaboration), and it has three key points:
- Collaboration - five leading neuroscientists, each with a specific scientific discipline (immunology, genetics, developmental biology, molecular biology and proteomics) collaborate at a much higher frequency than normal.
- Acceleration - increasing research speed through collaboration and research tools.
- Results - finding a myelin repair drug target for pharmaceutical licensure, where licensing revenues will be invested in ongoing research.
Listening to this episode, you get a real sense of the dedication and enthusiasm these scientists have to cure MS through finding a myelin repair drug target. Their research model has been featured in such publications as "The Definitive Drucker".
The Myelin Repair Foundation is a non-profit organization.
The episode can be found on iTunes and on the TWiT page under Futures in Biotech 14
No comments:
Post a Comment